Suppr超能文献

相似文献

1
PU.1 cooperates with IRF4 and IRF8 to suppress pre-B-cell leukemia.
Leukemia. 2016 Jun;30(6):1375-87. doi: 10.1038/leu.2016.27. Epub 2016 Mar 2.
3
Deletion of genes encoding PU.1 and Spi-B in B cells impairs differentiation and induces pre-B cell acute lymphoblastic leukemia.
Blood. 2011 Sep 8;118(10):2801-8. doi: 10.1182/blood-2011-02-335539. Epub 2011 Jul 18.
4
Transcription factors IRF8 and PU.1 are required for follicular B cell development and BCL6-driven germinal center responses.
Proc Natl Acad Sci U S A. 2019 May 7;116(19):9511-9520. doi: 10.1073/pnas.1901258116. Epub 2019 Apr 18.
5
IRF8 regulates B-cell lineage specification, commitment, and differentiation.
Blood. 2008 Nov 15;112(10):4028-38. doi: 10.1182/blood-2008-01-129049. Epub 2008 Sep 17.
6
Regulation of B cell linker protein transcription by PU.1 and Spi-B in murine B cell acute lymphoblastic leukemia.
J Immunol. 2012 Oct 1;189(7):3347-54. doi: 10.4049/jimmunol.1201267. Epub 2012 Sep 5.
7
PU.1 acts as tumor suppressor for myeloma cells through direct transcriptional repression of IRF4.
Oncogene. 2017 Aug;36(31):4481-4497. doi: 10.1038/onc.2017.79. Epub 2017 Apr 3.
9
PU.1 and IRF8 Modulate Activation of NLRP3 Inflammasome Regulating Its Expression in Human Macrophages.
Front Immunol. 2021 Apr 7;12:649572. doi: 10.3389/fimmu.2021.649572. eCollection 2021.
10
Transcription factors PU.1 and IRF4 regulate activation induced cytidine deaminase in chicken B cells.
Mol Immunol. 2010 Apr;47(7-8):1383-95. doi: 10.1016/j.molimm.2010.02.016. Epub 2010 Mar 17.

引用本文的文献

1
Antisense oligonucleotides targeting IRF4 alleviate psoriasis.
Acta Pharm Sin B. 2025 Jul;15(7):3575-3590. doi: 10.1016/j.apsb.2025.05.004. Epub 2025 May 14.
2
Cathepsin S: molecular mechanisms in inflammatory and immunological processes.
Front Immunol. 2025 Jul 7;16:1600206. doi: 10.3389/fimmu.2025.1600206. eCollection 2025.
4
The multiple roles of interferon regulatory factor family in health and disease.
Signal Transduct Target Ther. 2024 Oct 9;9(1):282. doi: 10.1038/s41392-024-01980-4.
5
ETS Transcription Factors in Immune Cells and Immune-Related Diseases.
Int J Mol Sci. 2024 Sep 17;25(18):10004. doi: 10.3390/ijms251810004.
6
Decreased PU.1 expression in mature B cells induces lymphomagenesis.
Cancer Sci. 2024 Dec;115(12):3890-3901. doi: 10.1111/cas.16344. Epub 2024 Sep 25.
8
The role of CD180 in hematological malignancies and inflammatory disorders.
Mol Med. 2023 Jul 17;29(1):97. doi: 10.1186/s10020-023-00682-x.
9
CRISPR/Cas9 editing reveals IRF8 regulated gene signatures restraining plasmablast differentiation.
Heliyon. 2023 Jun 21;9(6):e17527. doi: 10.1016/j.heliyon.2023.e17527. eCollection 2023 Jun.
10
ANP32B suppresses B-cell acute lymphoblastic leukemia through activation of PU.1 in mice.
Cancer Sci. 2023 Jul;114(7):2882-2894. doi: 10.1111/cas.15822. Epub 2023 May 3.

本文引用的文献

1
PU.1 opposes IL-7-dependent proliferation of developing B cells with involvement of the direct target gene bruton tyrosine kinase.
J Immunol. 2015 Jan 15;194(2):595-605. doi: 10.4049/jimmunol.1401569. Epub 2014 Dec 10.
2
The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation.
J Exp Med. 2014 Oct 20;211(11):2169-81. doi: 10.1084/jem.20140425. Epub 2014 Oct 6.
4
Stage-specific control of early B cell development by the transcription factor Ikaros.
Nat Immunol. 2014 Mar;15(3):283-93. doi: 10.1038/ni.2828. Epub 2014 Feb 9.
5
Ikaros is absolutely required for pre-B cell differentiation by attenuating IL-7 signals.
J Exp Med. 2013 Dec 16;210(13):2823-32. doi: 10.1084/jem.20131735. Epub 2013 Dec 2.
6
Cross talk between Wnt/β-catenin and Irf8 in leukemia progression and drug resistance.
J Exp Med. 2013 Oct 21;210(11):2239-56. doi: 10.1084/jem.20130706. Epub 2013 Oct 7.
7
Implication of IRF4 aberrant gene expression in the acute leukemias of childhood.
PLoS One. 2013 Aug 15;8(8):e72326. doi: 10.1371/journal.pone.0072326. eCollection 2013.
8
A role for IRF4 in the development of CLL.
Blood. 2013 Oct 17;122(16):2848-55. doi: 10.1182/blood-2013-03-492769. Epub 2013 Aug 7.
9
A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma.
Blood. 2013 Aug 1;122(5):726-33. doi: 10.1182/blood-2013-04-495804. Epub 2013 Jun 17.
10
Runx1 is essential at two stages of early murine B-cell development.
Blood. 2013 Jul 18;122(3):413-23. doi: 10.1182/blood-2013-01-480244. Epub 2013 May 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验